上市后监测报告发现了重度肝脏不良反应病例，包括肝脏坏死、黄疸、暴发性肝炎伴或不伴黄疸、肝衰竭等。

Postmarketing surveillance reports include cases of severe hepatic reactions, including liver necrosis, jaundice, fulminant hepatitis with and without jaundice, and liver failure.

youdao

在上市后监督后已报告的严重肝脏不良反应事件包括肝坏死、黄疸、伴有或不伴有黄疸的暴发性肝炎、肝衰竭。

Postmarketing surveillance has reported cases of severe hepatic reactions, including liver necrosis, jaundice, fulminant hepatitis with and without jaundice, and liver failure.

youdao